Avrobio Inc reported $238.1M in Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Akebia Therapeutics AKBA:US $ 611.86M 16.84M
Alnylam Pharmaceuticals ALNY:US $ 3509.43M 254.16M
Applied Genetic Technologies AGTC:US $ 126.97M 2.7M
Bluebird Bio BLUE:US $ 1454.46M 182.82M
Epizyme EPZM:US $ 352.55M 54.16M
Gilead Sciences GILD:US $ 67984M 492M
Intercept Pharmaceuticals ICPT:US $ 523.22M 3.11M
IONIS PHARMACEUT IONS:US $ 2497.07M 248.52M
Karyopharm Therapeutics KPTI:US $ 286.57M 11.66M
Macrogenics MGNX:US $ 425.91M 9.53M
Sangamo Biosciences SGMO:US $ 835.36M 41.73M
Sarepta Therapeutics SRPT:US $ 2759.07M 6.16M
Takeda 4502:JP Y 12657234M 255059M